Skip to content

Our
Technologies

External and implantable neuromodulation platforms built to deliver ARC Therapy.

Meet David Mzee and learn about his journey

Learn more

Our Mission

Driven to restore
Movement
Function
Independence
in people with spinal cord injury

Join our Patient Registry if you are interested in our clinical trials

Please complete this form to
contact us or receive updates

The ONWARD® Medical ARCEX® System is cleared for use only in the United States. ONWARD ARCIM® and ARCBCI™, alone or in combination with a brain-computer interface (BCI), are investigational and not available for commercial use.

*The ARCEX System is intended to deliver programmed, transcutaneous electrical spinal cord stimulation in conjunction with functional task practice in the clinic to improve hand sensation and strength in individuals between 18 and 75 years old that present with a chronic, non-progressive neurological deficit resulting from an incomplete spinal cord injury (C2-C8 inclusive).